Dimensional Fund Advisors’s SELLAS Life Sciences SLS Stock Holding History

Dimensional Fund Advisors’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31,304	Closed	-$44.8K	–	3512
2023 Q1	$44.8K	Buy	+31,304	New	+$77.4K	﹤0.01%	3392
2022 Q2	–	Sell	-15,924	Closed	-$106K	–	3523
2022 Q1	$106K	Hold	15,924	–	–	﹤0.01%	3389
2021 Q4	$88K	Hold	15,924	–	–	﹤0.01%	3450
2021 Q3	$146K	Sell	15,924 -4,396	-22%	-$40.8K	﹤0.01%	3387
2021 Q2	$226K	Buy	20,320 +4,911	+32%	+$47.9K	﹤0.01%	3318
2021 Q1	$132K	Hold	15,409	–	–	﹤0.01%	3326
2020 Q4	$90K	Hold	15,409	–	–	﹤0.01%	3282
2020 Q3	$41K	Buy	15,409 +3,500	+29%	+$9.59K	﹤0.01%	3311
2020 Q2	$35K	Hold	11,909	–	–	﹤0.01%	3321
2020 Q1	$21K	Hold	11,909	–	–	﹤0.01%	3350
2019 Q4	$51K	Buy	+11,909	New	+$64.1K	﹤0.01%	3347

Other funds holding SLS

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

OCG

Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return

PFG

Prosperity Financial Group San Ramon, California $323M AUM 35.79% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors's SLS Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of SELLAS Life Sciences (SLS) in Q2 2023, closing a stake of 31,304 shares — an estimated $44.8K sold.

Dimensional Fund Advisors first reported a position in SLS in Q4 2019 and held it in 11 quarters. The position peaked at $226K in Q2 2021. 25 funds tracked by Wall St. Rank hold SLS as of Q2 2023.

Dimensional Fund Advisors reported no remaining SELLAS Life Sciences position as of Q2 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 31,304 SELLAS Life Sciences shares in Q2 2023, an estimated $44.8K.
Dimensional Fund Advisors first reported a position in SELLAS Life Sciences in Q4 2019 and held it in 11 quarters.
Dimensional Fund Advisors's SELLAS Life Sciences position peaked at $226K in Q2 2021.
25 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.